Literature DB >> 11083479

Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes.

Q R Chen1, L Zhang, S A Stass, A J Mixson.   

Abstract

Development of nonviral delivery systems is progressing toward a transfection efficiency sufficient to affect metabolic and neoplastic diseases in humans. Nevertheless, inadequate transfection efficiency of target cells with current nonviral systems still limits the utility of this therapy. In the current study, we have determined that a co-polymer of histidine and lysine (H-K) enhances the transfection efficiency of liposomes, a leading nonviral system. We found that in the absence of serum, the addition of this polymer increased transfection as much as 10-fold in comparison with the liposome:DNA complex alone. More impressively, the co-polymer in the presence of serum increased transfection efficiency up to 100-fold. Furthermore, in vivo expression of luciferase in a tumor increased 15-fold with the addition of H-K polymer to the liposome:plasmid DNA complexes. Without liposomes, the H-K polymer had little to no effect on transfection efficiency. We anticipate that further modifications of this co-polymer will yield molecules with both increased complexity and transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083479     DOI: 10.1038/sj.gt.3301294

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  18 in total

1.  Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications.

Authors:  Jingsong Zhu; Paul W Luther; Qixin Leng; A James Mixson
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Branched co-polymers of histidine and lysine are efficient carriers of plasmids.

Authors:  Q R Chen; L Zhang; S A Stass; A J Mixson
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

3.  Optimal transfection with the HK polymer depends on its degree of branching and the pH of endocytic vesicles.

Authors:  Qing-Rong Chen; Lei Zhang; Paul W Luther; A James Mixson
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

Review 4.  Novel molecular approaches to cystic fibrosis gene therapy.

Authors:  Tim W R Lee; David A Matthews; G Eric Blair
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

Review 5.  Functional peptides for siRNA delivery.

Authors:  Wanyi Tai; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2016-08-13       Impact factor: 15.470

Review 6.  The benefits and challenges associated with the use of drug delivery systems in cancer therapy.

Authors:  Edna Cukierman; David R Khan
Journal:  Biochem Pharmacol       Date:  2010-04-22       Impact factor: 5.858

Review 7.  Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers.

Authors:  Patrick Midoux; Chantal Pichon; Jean-Jacques Yaouanc; Paul-Alain Jaffrès
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

8.  Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.

Authors:  Q Leng; P Scaria; P Lu; M C Woodle; A J Mixson
Journal:  Cancer Gene Ther       Date:  2008-05-16       Impact factor: 5.987

9.  Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide.

Authors:  Wei Yu; Kathleen F Pirollo; Bin Yu; Antonina Rait; Laiman Xiang; Weiqun Huang; Qi Zhou; Gözen Ertem; Esther H Chang
Journal:  Nucleic Acids Res       Date:  2004-03-16       Impact factor: 16.971

10.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.